BRIDGFORD FOODS CORP (BRID)

US1087631032 - Common Stock

10.5569  +0.05 (+0.44%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BRID. BRID was compared to 92 industry peers in the Food Products industry. While BRID has a great health rating, there are worries on its profitability. BRID does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

BRID had positive earnings in the past year.
BRID had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BRID reported negative operating cash flow in multiple years.

1.2 Ratios

BRID has a Return On Assets of 1.80%. This is comparable to the rest of the industry: BRID outperforms 50.55% of its industry peers.
Looking at the Return On Equity, with a value of 2.29%, BRID is in line with its industry, outperforming 50.55% of the companies in the same industry.
BRID has a Return On Invested Capital (1.74%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.8%
ROE 2.29%
ROIC 1.74%
ROA(3y)8.05%
ROA(5y)6.82%
ROE(3y)10.35%
ROE(5y)10.22%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BRID has a Profit Margin of 1.32%. This is comparable to the rest of the industry: BRID outperforms 48.35% of its industry peers.
In the last couple of years the Profit Margin of BRID has declined.
Looking at the Operating Margin, with a value of 1.52%, BRID is in line with its industry, outperforming 45.05% of the companies in the same industry.
BRID's Operating Margin has declined in the last couple of years.
BRID has a better Gross Margin (28.24%) than 72.53% of its industry peers.
In the last couple of years the Gross Margin of BRID has declined.
Industry RankSector Rank
OM 1.52%
PM (TTM) 1.32%
GM 28.24%
OM growth 3Y-4.3%
OM growth 5Y-12.85%
PM growth 3Y-27.92%
PM growth 5Y-18.02%
GM growth 3Y-2.38%
GM growth 5Y-2.91%

7

2. Health

2.1 Basic Checks

BRID has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BRID has less shares outstanding
BRID has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BRID has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 4.54 indicates that BRID is not in any danger for bankruptcy at the moment.
BRID has a Altman-Z score of 4.54. This is amongst the best in the industry. BRID outperforms 84.62% of its industry peers.
BRID has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BRID (0.02) is better than 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 4.54
ROIC/WACC0.19
WACC9.28%

2.3 Liquidity

BRID has a Current Ratio of 4.71. This indicates that BRID is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BRID (4.71) is better than 92.31% of its industry peers.
A Quick Ratio of 2.56 indicates that BRID has no problem at all paying its short term obligations.
BRID has a better Quick ratio (2.56) than 91.21% of its industry peers.
Industry RankSector Rank
Current Ratio 4.71
Quick Ratio 2.56

1

3. Growth

3.1 Past

The earnings per share for BRID have decreased strongly by -92.28% in the last year.
BRID shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.63% yearly.
The Revenue has decreased by -5.36% in the past year.
BRID shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.62% yearly.
EPS 1Y (TTM)-92.28%
EPS 3Y-22.11%
EPS 5Y-11.63%
EPS growth Q2QN/A
Revenue 1Y (TTM)-5.36%
Revenue growth 3Y8.32%
Revenue growth 5Y7.62%
Revenue growth Q2QN/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.05, BRID can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as BRID.
When comparing the Price/Earnings ratio of BRID to the average of the S&P500 Index (24.55), we can say BRID is valued slightly more expensively.
Industry RankSector Rank
PE 31.05
Fwd PE N/A

4.2 Price Multiples

83.52% of the companies in the same industry are more expensive than BRID, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.66

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BRID does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BRIDGFORD FOODS CORP

NASDAQ:BRID (5/1/2024, 7:00:03 PM)

10.5569

+0.05 (+0.44%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap95.86M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 31.05
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.8%
ROE 2.29%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.52%
PM (TTM) 1.32%
GM 28.24%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.71
Quick Ratio 2.56
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-92.28%
EPS 3Y-22.11%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-5.36%
Revenue growth 3Y8.32%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y